SANA · Sana Biotechnology, Inc. · Webcasts, Transcripts & Audio
$2.41
+0.11 (+4.77%)
At close · Oct 20
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 10, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Management has determined that our present capital resources may not be sufficient to fund our planned operations for at least one year from the date of this Quarterly Report, and there is substantial doubt as to our ability to continue as a going concern.”View the 10-Q filed Aug 10, 2026
Market Cap
$688.53M
Shares
299.36M
Volume · Oct 20
3.48M
Avg daily vol (3M)
3.2M
Sana Biotechnology, Inc. Webcasts
Earnings calls, investor updates, investor days and conferences for Sana Biotechnology, Inc. (SANA), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Pull transcripts and briefs through the earnings call transcript API or MCP →
Add these events to your calendar (.ics)
Conference
Investor event
2026-09-15
Sana Biotechnology, Inc. (SANA) September 15, 2026 Conference
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-09-14
Sana Biotechnology, Inc. (SANA) September 14, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-06-09
Sana Biotechnology, Inc. (SANA) June 9, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-06-03
Sana Biotechnology, Inc. (SANA) June 3, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-05-12
Sana Biotechnology, Inc. (SANA) May 12, 2026 Conference
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY25 · Q1
2025-05-08
Sana Biotechnology, Inc. (SANA) Q1 2025 Earnings Call Transcript
Confident tone
Clinical Catalysts and Timelines
Type 1 Diabetes / Hypoimmune Platform
Manufacturing Readiness
Diluted EPS
$-0.21
Audio
Transcript
Slides
8-K10-Q
Showing 1–6 of 6 webcasts
Key facts
CIK
1770121
CUSIP
799566104
13F (30d)
14 filings
14 filers
Visit website
Investor relations